Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-15-065265
Filing Date
2015-11-13
Accepted
2015-11-13 15:17:38
Documents
2
Period of Report
2015-12-09
Effectiveness Date
2015-11-13

Document Format Files

Seq Description Document Type Size
1 DEF 14A v423803_def14a.htm DEF 14A 531360
2 GRAPHIC tproxy1.jpg GRAPHIC 79457
  Complete submission text file 0001144204-15-065265.txt   642045
Mailing Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016
Business Address 430 EAST 29TH STREET SUITE 940 NEW YORK NY 10016 646-440-9310
IMMUNE PHARMACEUTICALS INC (Filer) CIK: 0001208261 (see all company filings)

EIN.: 521841431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36602 | Film No.: 151228837
SIC: 2834 Pharmaceutical Preparations